NCT00160069 - Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer | Biotech Hunter

Enrollment

128

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2009

Conditions

Carcinoma, Non Small Cell Lung

Interventions

DRUG

Sagopilone (BAY86-5302, ZK 219477)

16 mg/m2, 3-hour infusion, every 3 weeks

DRUG

Sagopilone (BAY86-5302, ZK 219477)

22 mg/m2, 30-min infusion, every 3 weeks

DRUG

Sagopilone (BAY86-5302, ZK 219477)

22 mg/m2, 3-hour infusion, every 3 weeks

Trial Locations (17)

12200

Berlin

14165

Berlin

17475

Greifswald

Stralsund

21075

Hamburg

22927

Großhansdorf

29325

Bremen

39130

Magdeburg

60590

Frankfurt am Main

65929

Frankfurt am Main

74245

Löwenstein

82131

Gauting

86156

Augsburg

90419

Nuremberg

96250

Ebensfeld

04103

Leipzig

06120

Halle